Pilaralisib analogue
CAS: 956958-53-5
Ref. TM-T2377
| 2mg | 38.00 € | ||
| 5mg | 54.00 € | ||
| 10mg | 86.00 € | ||
| 25mg | 137.00 € | ||
| 50mg | 212.00 € | ||
| 100mg | 365.00 € | ||
| 200mg | 475.00 € | ||
| 1ml*10 (DMSO) | 96.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
Product Information
Name:
Pilaralisib analogue
Synonyms:
- XL147 analogue, SAR245408
- SC
- N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide
- Pilaralisib
- Xl-147
- 3-Fluoro-5-formylbenzonitrile
- 3-Cyano-5-fluorobenzaldehyde
- N-(3-(benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenesulfonamide
- Benzonitrile, 3-fluoro-5-formyl-
- Xl147
- See more synonyms
- Sar245408
CAS:
Description:
Pilaralisib analogue (XL147 analogue) is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
448.52
Formula:
C21H16N6O2S2
Purity:
99.72%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T2377 Pilaralisib analogue
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
